FIELD: medicine, gastroenterology.
SUBSTANCE: it is necessary to apply omeprasol 20 mg twice daily, furasolidone at 100 mg thrice daily and hydrogen sulfide solution at concentration of 10 mg/l per 150 ml thrice daily. Therapeutic course corresponds to 10 d. Due to additional anti-Helicobacter impact of hydrogen sulfide solution at hydrogen sulfide concentration being 10 mg/l the present innovation provides efficient eradication of Helicobacter pylori without using antibiotics.
EFFECT: higher efficiency of therapy.
3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR TREATING THE CASES OF GASTRIC AND DUODENAL PEPTIC ULCER | 2004 |
|
RU2250767C1 |
METHOD FOR TREATING HELICOBACTER PYLORI-ASSOCIATED ULCEROUS GASTRIC AND DUODENAL DISEASE | 2006 |
|
RU2308949C1 |
METHOD TO TREAT ULCEROUS DUODENAL DISEASE | 2000 |
|
RU2184558C2 |
METHOD OF TREATING Helicobacter pylori ASSOCIATED CHRONIC ULCEROUS DISEASE OF STOMACH AND DUODENUM | 2010 |
|
RU2416408C1 |
METHOD OF TREATING Helicobacter pylori ASSOCIATED CHRONIC EROSIVE GASTRITIS | 2009 |
|
RU2403925C1 |
METHOD FOR TREATING HELICOBACTER-ASSOCIATED CHRONIC DUODENAL ULCER | 2003 |
|
RU2252777C2 |
METHOD OF TREATMENT OF PEPTIC ULCER OF STOMACH AND DUODENUM, ASSOCIATED WITH Helicobacter pylori | 2007 |
|
RU2352346C2 |
METHOD OF MEDICAL TREATMENT OF DUODENAL ULCER ASSOCIATED WITH Helicobacter pylori | 2006 |
|
RU2325918C2 |
PHARMACEUTICAL COMPOSITION OF PROTON PUMP INHIBITOR AND PREBIOTIC FOR TREATING GASTRIC AND DUODENAL ULCERS | 2009 |
|
RU2410100C2 |
ANTIHELICOBACTER THERAPY METHOD | 2005 |
|
RU2277931C1 |
Authors
Dates
2007-08-27—Published
2005-05-26—Filed